Navigation Links
Rigel Announces Fourth Quarter and Year End 2011 Financial Results
Date:3/6/2012

SOUTH SAN FRANCISCO, Calif., March 6, 2012 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today reported financial results for the fourth quarter and year ended December 31, 2011. For the fourth quarter of 2011, Rigel reported a net loss of $25.8 million, or $0.36 per share, compared to a net loss of $17.2 million, or $0.33 per share, in the fourth quarter of 2010. Weighted average shares outstanding for the fourth quarter of 2011 and 2010 were 71.2 million and 52.2 million, respectively.

Rigel reported total operating expenses of $25.9 million in the fourth quarter of 2011, compared to $19.7 million in the fourth quarter of 2010. The increase in operating expenses was primarily due to the increase in research and development expenses related to R343, its inhaled SYK inhibitor program for asthma, and R333, its topical JAK/SYK inhibitor program for discoid lupus.For the twelve months ended December 31, 2011, Rigel reported contract revenue from collaborations of approximately $4.8 million and net loss of $86.0 million, or $1.36 per basic and diluted share, compared to contract revenue of $125.0 million in 2010 and a net income of $37.9 million, or $0.73 and $0.72 per basic and diluted share, respectively.  The decrease in contract revenue from collaborations in 2011 was mainly due to the $100.0 million upfront payment received in 2010 pursuant to the exclusive worldwide license agreement with AstraZeneca AB (AZ) for fostamatinib, as well as $25.0 million in revenues earned from AZ in 2010 for the initiation of the Phase 3 clinical trial program with fostamatinib in patients with rheumatoid arthritis (RA) and the completion of the transfer of the fostamatinib open label extension study to AZ.

As of December 31, 2011, Rigel had cash, cash equivalents and available for sale securities of $247.6 million, compared to $177.3 million as of December 31, 2
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Rigel Announces Participation at Two Investor Conferences
2. Rigel Announces Initiation of Clinical Trials in Two Immunology Programs
3. Rigel to Present at Oppenheimer Annual Healthcare Conference
4. Rigel Announces Third Quarter 2011 Financial Results
5. Rigel to Present at Two Upcoming Investor Conferences
6. Rigel to Present at Wells Fargo Securities Healthcare Conference
7. Rigel to Present at Jefferies Global Healthcare Conference
8. Rigel Announces Pricing of Public Offering of Common Stock
9. Rigel Announces Proposed Public Offering of Common Stock
10. Rigel to Present at Bank of America Merrill Lynch Health Care Conference
11. Rigel Announces First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... 2015 /PRNewswire/ --Research and Markets ( http://www.researchandmarkets.com/research/vzcw2v/americas_clinical ... Chemistry Analyzer Market by Product, by End-Users - Forecast to ... Clinical Chemistry Analyzers market is estimated to grow at a ... the U.S., Canada , Mexico ... Americas (RoA) are covered in this report. The ...
(Date:5/1/2015)... 1, 2015 Following yesterday,s release of Center for ... are five things you need to know: ... is unique among government programs. ... different than other parts of Medicare and other government programs ... bids to offer prescription drug benefits to enrollees. , ...
(Date:5/1/2015)... and Markets ( http://www.researchandmarkets.com/research/pjbxjd/us_aco_it ) has announced ... Outlook 2018" report to their offering. ... ACO would grow at a CAGR of 22% during ... has been studied on three main grounds viz. spending ... Our research provides current market estimation and forecast till ...
Breaking Medicine Technology:Americas Clinical Chemistry Analyzer (Semi-Automated Clinical Chemistry and Fully-Automated Clinical Chemistry) Market - Forecast to 2019 25 Things to Know About the CMS Part D Data Release 25 Things to Know About the CMS Part D Data Release 3United States ACO IT Spending Outlook 2014-2018 2
... March 3, 2011 Dynatronics Corporation (Nasdaq: ... FirstChoice Cooperative, a group purchasing organization (GPO) headquartered in ... 20,000 members nationwide.  The three-year agreement with FirstChoice is ... the third GPO contract signed in the past two ...
... MASI ) today announced that its management is ... Conference at the Ritz-Carlton in Laguna Niguel, Calif. on Tuesday, ... of the presentation will be available on the Masimo website ... be available following the live presentation. ...
Cached Medicine Technology:Dynatronics Signs Third GPO Contract in Two Months 2Masimo to Present at the Roth Growth Stock Conference 2
(Date:5/2/2015)... 02, 2015 As a nonsurgical ... of the face, neck and décolleté, radiofrequency energy ... real potential for the success of vulvovaginal rejuvenation. ... Clinical Advisory Council, ThermiGyn’s Women’s Health Clinical Advisory ... concluded that ThermiGyn’s temperature controlled radio frequency, specifically ...
(Date:5/1/2015)... Frisco, Texas (PRWEB) May 02, 2015 ... Frisco, Texas, is proud to announce the addition of ... Jen Widerstrom is a life long athlete, growing up ... fitness passion after college by becoming a personal trainer ... since been the face of several TV shows highlighting ...
(Date:5/1/2015)... Jusuru International has been awarded the prestigious 2015 ... flagship nutritional supplement, Liquid BioCell™ Life, and the relaunch ... logo, new packaging, new products, and new messaging. ... and promote programs that serve as examples of direct ... International for their outstanding accomplishments and contributions to direct ...
(Date:5/1/2015)... May 01, 2015 TROY Healthcare Solutions ... Southeast Regional User Group (RUG) Conference in Atlanta, GA ... Regional User Group Conference provides a forum for client-to-client ... support all aspects of electronic medical record operations, as ... software applications. , In addition to sponsoring the event, ...
(Date:5/1/2015)... KY (PRWEB) May 01, 2015 Ernst ... CEO, Dr. Joshua Rosenthal, Co-Founder & CSO, and Burak ... finalists for the EY Entrepreneur Of The Year® ... Ernst & Young is a global leader in ... to be one of the top audit companies ...
Breaking Medicine News(10 mins):Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 3Health News:IDLife LLC Announces New Partnership with Fitness Celebrity, Jen Widerstrom 2Health News:Jusuru International Receives 2015 DSA Ethos Award 2Health News:Jusuru International Receives 2015 DSA Ethos Award 3Health News:Jusuru International Receives 2015 DSA Ethos Award 4Health News:Jusuru International Receives 2015 DSA Ethos Award 5Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 3Health News:RowdMap, Inc. Named as a Ernst & Young Entrepreneur Of The Year® 2015 Award Finalist 2
... Serena Gordon HealthDay Reporter , THURSDAY, May 19 ... is especially tough, say allergy experts. "Everyone always ... worst year ever for allergies," said Dr. David Rosenstreich, director ... in New York City. But this year those complaints ...
... from the American Cancer Society details cancer control efforts and ... contribute to cancer mortality. Increasing rates of obesity observed since ... decade, particularly among women and girls, but nearly one in ... Vaccination against the virus that causes cervical cancer is up, ...
... Theurer Cancer Center at Hackensack University Medical Center,s Cutaneous Malignancies ... skin cancer screening event on Thursday, June 2 from 10am ... cancer prevention and offer free skin cancer screenings by appointment ... be a devastating disease, but when caught early it is ...
... of studies on whether moderate exercise can curb the ... an apparent contradiction: it seems to work in short-term, ... treatment trials. A new study may explain why and ... suggested in the results of research led by David ...
... Clinical Oncology (ASCO) today highlighted several studies in a ... posted online at www.asco.org in advance of ASCO,s 47th ... other major studies will be released in on-site press ... meeting, which is expected to draw approximately 30,000 cancer ...
... This release is available in German . ... future, doctors will be able to take a closer look at ... a few fractions of a second. It examines to a resolution ... images so quickly that the results are not blurred even if ...
Cached Medicine News:Health News:Springtime and the Sneezin' Is Easy 2Health News:Springtime and the Sneezin' Is Easy 3Health News:Report outlines successes, challenges in cancer prevention efforts 2Health News:Report outlines successes, challenges in cancer prevention efforts 3Health News:Exercise helps women fight smoking cravings, but effect is short-lived 2Health News:ASCO releases studies from upcoming annual meeting 2Health News:ASCO releases studies from upcoming annual meeting 3Health News:Microscope -- handy, quick and flat 2Health News:Microscope -- handy, quick and flat 3
Angled insertion forcep used for the Hydroview lens. Manufactured in titanium....
Titanium. Curved 18 mm shafts with 1.5 wide grasping tip. Flat, serrated cross action handle with dull finish....
30 degree angled tip with 45 mm tip opening. Made with lock. Manufactured in titanium....
Straight 25 gauge shaft with angled tip and sliding inner shaft. Shaft holds the proximal loop against the angled tip while handle in the normal state. Squeeze type handle with dull finish....
Medicine Products: